5-hydroxytryptophan has been researched along with Sclerosis, Systemic in 4 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rush, PJ | 1 |
| Bell, MJ | 1 |
| Fam, AG | 1 |
| Fine, RM | 1 |
| Sternberg, EM | 1 |
| Van Woert, MH | 1 |
| Young, SN | 1 |
| Magnussen, I | 1 |
| Baker, H | 1 |
| Gauthier, S | 1 |
| Osterland, CK | 1 |
| Chamson, A | 1 |
| Périer, C | 1 |
| Frey, J | 1 |
1 trial available for 5-hydroxytryptophan and Sclerosis, Systemic
| Article | Year |
|---|---|
Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Therapy, Com | 1980 |
3 other studies available for 5-hydroxytryptophan and Sclerosis, Systemic
| Article | Year |
|---|---|
Toxic oil syndrome (Spanish oil disease) and chemically induced scleroderma-like conditions.
Topics: 5-Hydroxytryptophan; Bleomycin; Brassica; Carbidopa; Humans; Oils; Pentazocine; Plastics; Scleroderm | 1984 |
Drug-related scleroderma-like illness. The Fine page.
Topics: 5-Hydroxytryptophan; Carbidopa; Drug Combinations; Humans; Kynurenine; Scleroderma, Systemic | 1981 |
[Sclerodermiform and poikilodermic syndrome during treatment with carbidopa and 5-hydroxytryptophan. Culture of fibroblasts with biochemical analysis of collagen metabolism].
Topics: 5-Hydroxytryptophan; Carbidopa; Cells, Cultured; Collagen; Drug Therapy, Combination; Fibroblasts; H | 1986 |